What is the level of liabilities of Lupin this year?
Lupin has a debt balance of 97.07 B INR this year.
Lupin Liabilities 2024
Lupin Liabilities
97.07 B INR
Ticker
LUPIN.NS
ISIN
INE326A01037
In 2024, Lupin's total liabilities amounted to 97.07 B INR, a 0.4% difference from the 96.68 B INR total liabilities in the previous year.
Lupin Aktienanalyse
What does Lupin do?
Lupin Limited is an Indian pharmaceutical company specializing in generics and novel therapies. It was founded in 1968 by Dr. Desh Bandhu Gupta and has experienced rapid growth, becoming one of the leading companies in the global pharmaceutical market. The company's business model involves manufacturing and marketing generics and novel therapies for the treatment of various diseases such as cancer, diabetes, cardiovascular diseases, and respiratory diseases. Lupin operates worldwide with a wide range of partners to distribute its products in over 100 countries. The company is involved in various divisions including generics, novel therapies, biosimilars, and inhalation products. Lupin's generics division encompasses a wide range of products such as antibiotics, antidepressants, antihypertensives, and many other categories. Its novel therapies include innovative products for the treatment of diabetes, cancer, multiple sclerosis, and other chronic diseases. Lupin is also involved in the development of biosimilars, which are imitation biopharmaceuticals manufactured using living organisms. Lastly, the company offers inhalation products for the treatment of respiratory diseases such as asthma and COPD. Lupin has built an impressive product pipeline over the years, having submitted over 174 ANDA applications (for the approval of new generics) to the US FDA and introduced more than 80 new products in the Indian market. It has also established an innovative research and development center that focuses on the discovery of new molecules and the development of new therapeutic approaches. Another important feature of Lupin is its commitment to quality and sustainability. The company has received numerous awards for its product quality and environmental initiatives. In 2019, Lupin received the Sustainable Business Award from CNBC TV18. Overall, Lupin Limited is a successful and fast-growing company specializing in generics and novel therapies. It has a wide range of products and an impressive pipeline, and operates globally. Due to its commitment to quality and sustainability, Lupin Limited has also built a strong reputation among its customers and partners. Lupin ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Lupin's Liabilities
Lupin's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Lupin's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Lupin's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Lupin's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Lupin’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Lupin stock
What were the liabilities of Lupin compared to the previous year?
The liabilities of Lupin have increased by 0.4% increased compared to the previous year.
What are the consequences of high debt for investors of Lupin?
High liabilities can pose a risk for investors of Lupin, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Lupin?
Low liabilities mean that Lupin has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Lupin affect the company?
An increase in liabilities of Lupin can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Lupin affect the company?
A decrease in the liabilities of Lupin can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Lupin?
Some factors that can influence the liabilities of Lupin include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Lupin so important for investors?
The liabilities of Lupin are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Lupin take to modify the liabilities?
To change its liabilities, Lupin can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Lupin pay?
Over the past 12 months, Lupin paid a dividend of 8 INR . This corresponds to a dividend yield of about 0.38 %. For the coming 12 months, Lupin is expected to pay a dividend of 7.37 INR.
What is the dividend yield of Lupin?
The current dividend yield of Lupin is 0.38 %.
When does Lupin pay dividends?
Lupin pays a quarterly dividend. This is distributed in the months of August, August, August, August.
How secure is the dividend of Lupin?
Lupin paid dividends every year for the past 23 years.
What is the dividend of Lupin?
For the upcoming 12 months, dividends amounting to 7.37 INR are expected. This corresponds to a dividend yield of 0.35 %.
In which sector is Lupin located?
Lupin is assigned to the 'Health' sector.
Wann musste ich die Aktien von Lupin kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Lupin from 9/1/2024 amounting to 8 INR, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.
When did Lupin pay the last dividend?
The last dividend was paid out on 9/1/2024.
What was the dividend of Lupin in the year 2023?
In the year 2023, Lupin distributed 4 INR as dividends.
In which currency does Lupin pay out the dividend?
The dividends of Lupin are distributed in INR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Lupin
Our stock analysis for Lupin Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lupin Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.